Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Ceretas Completes Ultrasound Device Prototypes, Triggering Final Grant Payment

Ceretas Limited (CTS) · Health care

CTS: $0.920 +2.22% · MC: $67M

Ceretas completed functional prototypes of navigation software and a lift-assist device intended to enable single-operator ultrasound treatment and reduce device costs. The milestone triggered the final payment under its government-backed grant. The company also secured full ownership of its core intellectual property during the quarter and said its IPO fully funded its Phase 2 Alzheimer’s trial. Ceretas reported yesterday that the trial’s first patient had enrolled ahead of its year-end target.

Source announcements: 2026-10-30 09:23 to 2026-10-30 09:23 Sydney time
Story updated 2026-10-30 10:39 Sydney time
SourcesQuarterly Activities/Appendix 4C Cash Flow Report
Comments